ATE296281T1 - Verwendung von aminen - Google Patents
Verwendung von aminenInfo
- Publication number
- ATE296281T1 ATE296281T1 AT01926240T AT01926240T ATE296281T1 AT E296281 T1 ATE296281 T1 AT E296281T1 AT 01926240 T AT01926240 T AT 01926240T AT 01926240 T AT01926240 T AT 01926240T AT E296281 T1 ATE296281 T1 AT E296281T1
- Authority
- AT
- Austria
- Prior art keywords
- combatting
- amines
- activation
- preventing
- kinin
- Prior art date
Links
- 150000001412 amines Chemical class 0.000 title abstract 3
- 230000004913 activation Effects 0.000 abstract 2
- 102000001399 Kallikrein Human genes 0.000 abstract 1
- 108060005987 Kallikrein Proteins 0.000 abstract 1
- 102000002397 Kinins Human genes 0.000 abstract 1
- 108010093008 Kinins Proteins 0.000 abstract 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 abstract 1
- 230000023555 blood coagulation Effects 0.000 abstract 1
- 230000024203 complement activation Effects 0.000 abstract 1
- 229960003194 meglumine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Lubricants (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0007239.7A GB0007239D0 (en) | 2000-03-24 | 2000-03-24 | Use |
| PCT/NO2001/000123 WO2001072669A2 (en) | 2000-03-24 | 2001-03-22 | Therapeutic use of polyhydroxy amine derivates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE296281T1 true ATE296281T1 (de) | 2005-06-15 |
Family
ID=9888396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01926240T ATE296281T1 (de) | 2000-03-24 | 2001-03-22 | Verwendung von aminen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7060731B2 (de) |
| EP (1) | EP1282592B1 (de) |
| JP (1) | JP2003528836A (de) |
| AT (1) | ATE296281T1 (de) |
| AU (1) | AU2001252772A1 (de) |
| DE (1) | DE60111044T2 (de) |
| GB (1) | GB0007239D0 (de) |
| WO (1) | WO2001072669A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060100127A1 (en) | 2004-11-11 | 2006-05-11 | Meier Ingrid K | N,N-dialkylpolyhydroxyalkylamines |
| US8061515B2 (en) * | 2010-02-19 | 2011-11-22 | Michael Carrasquillo | Compact disc storage and protective enclosure |
| JP6491747B2 (ja) * | 2015-09-30 | 2019-03-27 | デューク・ユニヴァーシティ | 磁気共鳴画像法用の造影剤 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2919229A (en) * | 1957-11-22 | 1959-12-29 | Us Vitamin Corp | N-methylglucamine salts of alphanaphthyl and acyl 1, 3-indandione and methods of using same |
| US3906109A (en) * | 1972-02-09 | 1975-09-16 | Dan Christian Roehm | Blood clotting depressant therapy |
| JPH0678241B2 (ja) * | 1986-04-02 | 1994-10-05 | エーザイ株式会社 | ｔＰＡ医薬組成物 |
| US5028625A (en) * | 1989-06-20 | 1991-07-02 | American Home Products Corporation | Acid addition salt of ibuprofen and meglumine |
| IL98744A0 (en) * | 1990-07-06 | 1992-07-15 | Gen Hospital Corp | Method of studying biological tissue using monocrystalline particles |
| ES2177644T3 (es) * | 1994-04-12 | 2002-12-16 | Arakis Ltd | Procedimiento para la resolucion de etodolac utilizando derivados de glucamina. |
| EP0767777B1 (de) * | 1994-06-29 | 1999-04-14 | Novartis AG | Salze von 2-[(2,6-dichlorophenyl)amin]phenylacetoxyessigsäure mit organischen basischen kationen |
| AU1885999A (en) * | 1998-02-17 | 1999-08-30 | Miciopharma Chemical Aktiengesellschaft | A watersoluble nimesulide adduct also for injectable use |
| US6093743A (en) * | 1998-06-23 | 2000-07-25 | Medinox Inc. | Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
-
2000
- 2000-03-24 GB GBGB0007239.7A patent/GB0007239D0/en not_active Ceased
-
2001
- 2001-03-22 DE DE60111044T patent/DE60111044T2/de not_active Expired - Lifetime
- 2001-03-22 AU AU2001252772A patent/AU2001252772A1/en not_active Abandoned
- 2001-03-22 EP EP01926240A patent/EP1282592B1/de not_active Expired - Lifetime
- 2001-03-22 JP JP2001570585A patent/JP2003528836A/ja active Pending
- 2001-03-22 WO PCT/NO2001/000123 patent/WO2001072669A2/en not_active Ceased
- 2001-03-22 AT AT01926240T patent/ATE296281T1/de not_active IP Right Cessation
-
2002
- 2002-09-12 US US10/242,082 patent/US7060731B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20030045586A1 (en) | 2003-03-06 |
| EP1282592B1 (de) | 2005-05-25 |
| EP1282592A2 (de) | 2003-02-12 |
| WO2001072669A3 (en) | 2002-01-03 |
| JP2003528836A (ja) | 2003-09-30 |
| GB0007239D0 (en) | 2000-05-17 |
| WO2001072669A2 (en) | 2001-10-04 |
| DE60111044T2 (de) | 2006-05-04 |
| US7060731B2 (en) | 2006-06-13 |
| DE60111044D1 (de) | 2005-06-30 |
| AU2001252772A1 (en) | 2001-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9916111A (pt) | Derivados de fenilglicina | |
| BR9806752A (pt) | Ftalazinonas. | |
| ATE289598T1 (de) | Glutamin-thiazolidide und -pyrrolidide sowie ihre verwendung als dipeptidylpeptidase iv inhibitoren | |
| TR200002480T2 (tr) | İzaşemi tedavisi için guanidin türevleri | |
| BR0215405A (pt) | Composições e processos de uso de collajolie | |
| TR200103493T2 (tr) | Metaloproteaz önleyicileri | |
| BR0007527A (pt) | Fenilfenantridinas com atividade inibitória depde-iv | |
| DE69504383D1 (de) | Bisulfit-Additionsverbindungen von Argininaldehyden und ihre Verwendung als Thrombininhibitoren und Antikoagulantien | |
| BR0014078A (pt) | Inibidores de fator xa | |
| NO992492L (no) | Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer | |
| BR0207278A (pt) | Derivados de ftalazinona-piperidina como inibidores de pde4 | |
| DK0998460T3 (da) | Hidtil ukendte tetrazolderivater | |
| TR200200883T2 (tr) | 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları | |
| DE60017878D1 (de) | Kombinationspräparate zur behandlung von erkrankungen, die mit angiogenese verbunden sind | |
| WO2002070469A3 (en) | Selective pde3b inhibitors and use of the same in therapy | |
| BR0315662A (pt) | Derivados de 1-(4-benzil-piperazin-1-il)-3-fenil-propenona | |
| TR200201128T2 (tr) | PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. | |
| TR200001909T2 (tr) | Matris metaloprotez inhibitörleri. | |
| DK1015437T3 (da) | Benzoxazin- og benzothiazin-derivater og deres anvendelse i lægemidler | |
| DE50109698D1 (de) | N-heteroarylmethyl-m-phenylendiamin-derivate enthaltende färbemittel für keratinfasern sowie neue n-heteroarylmethyl-m-phenylendiamin-derivate | |
| ATE296281T1 (de) | Verwendung von aminen | |
| DE60131968D1 (de) | PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN | |
| BR9912307A (pt) | Inibidores fkbp | |
| DK1248651T3 (da) | Produkt omfattende en heterotrimer G-proteinsignaltransduktionshæmmer kombineret med et antihypertensivt middel til terapeutisk anvendelse i behandlingen af arteriel hypertension | |
| DE50111407D1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |